Insider Selling: Trulieve Cannabis (NYSE:TRLV) CEO Sells $1,287,327.60 in Stock

Trulieve Cannabis Corp. (NYSE:TRLV) CEO Kim Rivers sold 137,535 shares of the company’s stock in a transaction that occurred on Wednesday, June 17th. The shares were sold at an average price of $9.36, for a total value of $1,287,327.60. Following the transaction, the chief executive officer directly owned 3,038,385 shares of the company’s stock, valued at $28,439,283.60. This trade represents a 4.33% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Trulieve Cannabis Price Performance

Shares of Trulieve Cannabis stock opened at $8.53 on Thursday. Trulieve Cannabis Corp. has a twelve month low of $3.42 and a twelve month high of $13.28.

Analyst Ratings Changes

Several equities research analysts have weighed in on TRLV shares. Weiss Ratings assumed coverage on Trulieve Cannabis in a research report on Tuesday, June 16th. They issued a “sell (d-)” rating on the stock. Zacks Research raised shares of Trulieve Cannabis to a “hold” rating in a report on Thursday, June 18th. One research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Reduce”.

Trulieve Cannabis Company Profile

Trulieve Cannabis Corp. is a vertically integrated cannabis company focused on the cultivation, processing, and retail sale of medical and adult-use cannabis products. The company offers a range of products that may include flower, pre-rolls, concentrates, edibles, vape products, and topicals through its dispensary network and branded product portfolio.

Trulieve’s operations have been centered primarily in the United States, with a strong presence in Florida and additional markets in other states where cannabis is legally regulated.